Other adenocarcinomas, such as those from the pancreas (84.3%), the gallbladder (77.1%), the stomach (24.4%), the esophagus (36.4%), the lung (92.1%), or the prostate (56.7%) had markedly higher rates of moderate-to-strong GR positivity. This evidence concerns the gene NR3C1 and adenocarcinoma.